ES2886914T3 - Acido (R)-3-(4'-(2-(2-metilpirrolidin-1-il)etil)-bifenil-4-il)propanoico como moduladores del receptor de histamina H3 para el tratamiento de trastornos cognitivos - Google Patents
Acido (R)-3-(4'-(2-(2-metilpirrolidin-1-il)etil)-bifenil-4-il)propanoico como moduladores del receptor de histamina H3 para el tratamiento de trastornos cognitivos Download PDFInfo
- Publication number
- ES2886914T3 ES2886914T3 ES17186099T ES17186099T ES2886914T3 ES 2886914 T3 ES2886914 T3 ES 2886914T3 ES 17186099 T ES17186099 T ES 17186099T ES 17186099 T ES17186099 T ES 17186099T ES 2886914 T3 ES2886914 T3 ES 2886914T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- ethyl
- methylpyrrolidin
- receptor
- biphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *C1N(CCc2ccc(*)cc2)CCC1 Chemical compound *C1N(CCc2ccc(*)cc2)CCC1 0.000 description 6
- KVZJLSYJROEPSQ-UHFFFAOYSA-N CC1C(C)CCCC1 Chemical compound CC1C(C)CCCC1 KVZJLSYJROEPSQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361750475P | 2013-01-09 | 2013-01-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2886914T3 true ES2886914T3 (es) | 2021-12-21 |
Family
ID=50000114
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14701137.3T Active ES2647965T3 (es) | 2013-01-09 | 2014-01-08 | Derivados de bifenil-etil-pirrolidina como moduladores del receptor de histamina H3 para el tratamiento de trastornos cognitivos |
| ES17186099T Active ES2886914T3 (es) | 2013-01-09 | 2014-01-08 | Acido (R)-3-(4'-(2-(2-metilpirrolidin-1-il)etil)-bifenil-4-il)propanoico como moduladores del receptor de histamina H3 para el tratamiento de trastornos cognitivos |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14701137.3T Active ES2647965T3 (es) | 2013-01-09 | 2014-01-08 | Derivados de bifenil-etil-pirrolidina como moduladores del receptor de histamina H3 para el tratamiento de trastornos cognitivos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9365511B2 (lt) |
| EP (3) | EP2943473B1 (lt) |
| JP (1) | JP6253668B2 (lt) |
| CN (1) | CN105263914B (lt) |
| DK (1) | DK3309150T3 (lt) |
| ES (2) | ES2647965T3 (lt) |
| HK (2) | HK1219953A1 (lt) |
| LT (1) | LT3309150T (lt) |
| PT (1) | PT3309150T (lt) |
| WO (1) | WO2014110103A1 (lt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3391886A1 (en) | 2017-04-19 | 2018-10-24 | Novartis AG | The use of a h3r inverse agonist for the treatment of shift work disorder |
| WO2022113008A1 (en) | 2020-11-27 | 2022-06-02 | Richter Gedeon Nyrt. | Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder |
| WO2023191425A1 (ko) * | 2022-03-28 | 2023-10-05 | 주식회사 비엔에이치리서치 | 약물의 전기생리학적 스크리닝 방법 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5217986A (en) | 1992-03-26 | 1993-06-08 | Harbor Branch Oceanographic Institution, Inc. | Anti-allergy agent |
| US5352707A (en) | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
| US5869479A (en) | 1997-08-14 | 1999-02-09 | Schering Corporation | Treatment of upper airway allergic responses |
| WO2002074758A2 (en) * | 2001-03-16 | 2002-09-26 | Abbott Laboratories | Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| MXPA05005116A (es) * | 2002-11-12 | 2005-07-01 | Abbott Lab | Aminas biciclicas sustituidas en la forma de ligandos del receptor de histamina-3. |
| US20050245543A1 (en) * | 2004-04-30 | 2005-11-03 | Pfizer Inc | Histamine-3 receptor antagonists |
| RS51403B (en) * | 2004-05-07 | 2011-02-28 | Warner-Lambert Company Llc | DERIVATIVES OF 3-OR 4-MONOSUBSTITIZED PHENOLS AND THIOPHENOLS USEFUL AS H3 LIGANDS |
| US20060014733A1 (en) * | 2004-07-19 | 2006-01-19 | Pfizer Inc | Histamine-3 agonists and antagonists |
| EP2035372A1 (en) * | 2006-06-29 | 2009-03-18 | Arena Pharmaceuticals, Inc. | Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| TW200823204A (en) * | 2006-10-17 | 2008-06-01 | Arena Pharm Inc | Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto |
| CN101910155A (zh) * | 2007-10-30 | 2010-12-08 | 艾尼纳制药公司 | 作为组胺-h3受体调节剂用于治疗与组胺-h3受体调节剂相关的障碍的联苯衍生物 |
-
2014
- 2014-01-08 DK DK17186099.2T patent/DK3309150T3/da active
- 2014-01-08 ES ES14701137.3T patent/ES2647965T3/es active Active
- 2014-01-08 JP JP2015551856A patent/JP6253668B2/ja active Active
- 2014-01-08 EP EP14701137.3A patent/EP2943473B1/en active Active
- 2014-01-08 WO PCT/US2014/010632 patent/WO2014110103A1/en active Application Filing
- 2014-01-08 US US14/760,022 patent/US9365511B2/en active Active
- 2014-01-08 EP EP21169065.6A patent/EP3889141A1/en not_active Withdrawn
- 2014-01-08 CN CN201480004448.9A patent/CN105263914B/zh active Active
- 2014-01-08 ES ES17186099T patent/ES2886914T3/es active Active
- 2014-01-08 LT LTEP17186099.2T patent/LT3309150T/lt unknown
- 2014-01-08 PT PT171860992T patent/PT3309150T/pt unknown
- 2014-01-08 EP EP17186099.2A patent/EP3309150B1/en active Active
-
2016
- 2016-07-11 HK HK16108051.1A patent/HK1219953A1/zh unknown
-
2018
- 2018-09-27 HK HK18112396.5A patent/HK1253019A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016504388A (ja) | 2016-02-12 |
| CN105263914B (zh) | 2017-10-27 |
| WO2014110103A1 (en) | 2014-07-17 |
| HK1219953A1 (zh) | 2017-04-21 |
| CN105263914A (zh) | 2016-01-20 |
| EP3889141A1 (en) | 2021-10-06 |
| ES2647965T3 (es) | 2017-12-27 |
| JP6253668B2 (ja) | 2017-12-27 |
| EP3309150A1 (en) | 2018-04-18 |
| US9365511B2 (en) | 2016-06-14 |
| DK3309150T3 (da) | 2021-08-30 |
| EP2943473A1 (en) | 2015-11-18 |
| HK1253019A1 (zh) | 2019-06-06 |
| US20150353488A1 (en) | 2015-12-10 |
| EP2943473B1 (en) | 2017-08-23 |
| PT3309150T (pt) | 2021-08-31 |
| EP3309150B1 (en) | 2021-06-02 |
| LT3309150T (lt) | 2021-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2759615T3 (es) | Análogos de N-fenilpirimidina-2-amina sustituidos como inhibidores de la quinasa AXL | |
| ES2250464T3 (es) | Derivados de piridina 2,4- sustituidos. | |
| ES2915266T3 (es) | Derivados de N-[2-(1-bencilpiperidin-4-il)etil]-4-(pirazin-2-il)-piperazin-1-carboxamida y compuestos relacionados como antagonistas del receptor muscarínico 4 (M4) para el tratamiento de enfermedades neurológicas | |
| CN104395323B (zh) | 可透过性糖苷酶抑制剂及其用途 | |
| US8658131B2 (en) | Compounds comprising 4-benzoylpiperidine as a sigma-1-selective ligand | |
| CN110709386B (zh) | 双环杂芳基衍生物及其制备与用途 | |
| BR112017007123B1 (pt) | Composto representado pela fórmula (i-a), ou um seu sal farmaceuticamente aceitável, uso de um composto de fórmula (ia) e composição farmacêutica | |
| ES2932441T3 (es) | Formas cristalinas y procesos para la preparación de azaciclos condensados (moduladores de los receptores cannabinoides) | |
| ES2787599T3 (es) | Inhibidores de leucemia inv(16) | |
| ES2435651T3 (es) | Agonistas de MGLU2 | |
| ES2929140T3 (es) | Imidazoles sustituidos con fenilo y piridinilo como moduladores de RORgammat | |
| KR20110098725A (ko) | Ｃｘｃｒ７의 모듈레이터 | |
| AU2017319080B2 (en) | Pyrazolo[1,5-a]pyrimidine compound | |
| CN102036967A (zh) | 作为5-ht6拮抗剂的芳基磺酰基吡唑啉甲脒衍生物 | |
| ES2886914T3 (es) | Acido (R)-3-(4'-(2-(2-metilpirrolidin-1-il)etil)-bifenil-4-il)propanoico como moduladores del receptor de histamina H3 para el tratamiento de trastornos cognitivos | |
| CN107531615A (zh) | 茚基化合物、药物组合物及其医药用途 | |
| JP2011512355A (ja) | ヒスタミンｈ３受容体関連障害の治療において有用なヒスタミンｈ３受容体の調節剤 | |
| TW201713623A (zh) | １，２，３，４－四氫異喹啉衍生物、其製備方法和應用 | |
| JP2018500382A (ja) | 新規カルシウム調節剤 | |
| WO2020169042A1 (zh) | 6-氧代-1,6-二氢哒嗪类前药衍生物、其制备方法及其在医药上的应用 | |
| Thorat et al. | 2-(3-Fluoro-4-methylsulfonylaminophenyl) propanamides as potent TRPV1 antagonists: Structure activity relationships of the 2-oxy pyridine C-region | |
| ES2852275T3 (es) | Derivado de adamantano y uso del mismo | |
| WO2020253762A1 (zh) | 吲唑类衍生物、其制备方法及其在医药上的应用 | |
| WO2016064682A1 (en) | Selective inhibitors of constitutive androstane receptor | |
| ES2774349T3 (es) | Derivado de 3-azabiciclo[3.1.0]hexano y su uso para fines médicos |